233 related articles for article (PubMed ID: 35876787)
1. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Schink T; Princk C; Braitmaier M; Haug U
BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
[TBL] [Abstract][Full Text] [Related]
2. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
4. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
6. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
Jick SS; Hernandez RK
BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
[TBL] [Abstract][Full Text] [Related]
7. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB
BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
9. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
[TBL] [Abstract][Full Text] [Related]
11. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
[TBL] [Abstract][Full Text] [Related]
12. Combined oral contraceptives: venous thrombosis.
de Bastos M; Stegeman BH; Rosendaal FR; Van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010813. PubMed ID: 24590565
[TBL] [Abstract][Full Text] [Related]
13. Systemic hormonal contraception and risk of venous thromboembolism.
Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
[TBL] [Abstract][Full Text] [Related]
14. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
15. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
[TBL] [Abstract][Full Text] [Related]
16. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Odlind V; Milsom I; Persson I; Victor A
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae KD; Tyrer F; Leydon GM
Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
Parkin L; Sharples K; Hernandez RK; Jick SS
BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
[TBL] [Abstract][Full Text] [Related]
20. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
